SSRIs lower sodium levels primarily by triggering the body to release too much antidiuretic hormone (ADH), a hormone that tells your kidneys to hold onto water. The excess water dilutes sodium in your blood, creating a condition called hyponatremia. This typically happens within the first two weeks of starting or increasing the dose, with a median onset around 9 days.
The Mechanism: Too Much Water Retention
Under normal conditions, your brain releases ADH when you’re dehydrated. ADH signals your kidneys to reabsorb water rather than excrete it in urine, keeping your body’s fluid balance in check. Once your hydration is adequate, the signal stops and your kidneys go back to filtering normally.
SSRIs disrupt this cycle. While their primary target is serotonin, they also affect norepinephrine, another chemical messenger in the brain. Norepinephrine normally stimulates a specific receptor (the alpha-1 adrenergic receptor) that triggers ADH release, then gets broken down, ending the signal. When an SSRI blocks norepinephrine from being reabsorbed, that signal keeps firing. The result is a sustained, inappropriate release of ADH, well beyond what your hydration status actually calls for.
This creates a condition called SIADH, or syndrome of inappropriate antidiuretic hormone secretion. Your kidneys respond to all that extra ADH by holding onto water. The water floods into your bloodstream, diluting the sodium that’s already there. Your total sodium may not have changed much, but its concentration drops because there’s too much water surrounding it. That dilution is what shows up on blood work as hyponatremia, defined as a sodium level below 135 mmol/L.
How Quickly It Develops
In a 12-week prospective study of older adults starting paroxetine (a common SSRI), hyponatremia developed at a median of 9 days after the first dose. The range was wide: one patient developed symptoms within 24 hours, while others took up to 14 days. This means the highest-risk window is roughly the first one to two weeks after starting or increasing your dose, though it can happen later.
Who Is Most at Risk
Older age is the single biggest risk factor. Studies of older psychiatric inpatients starting SSRIs or similar antidepressants have found hyponatremia rates between 9% and 39%, depending on how it was measured and the population studied. For comparison, the general rate of hyponatremia among all hospitalized adults is 15% to 30%, making antidepressant-related cases a meaningful addition to that baseline risk.
Taking diuretics (water pills) alongside an SSRI compounds the problem significantly. Diuretics already push sodium out through urine, so when you add SSRI-driven water retention on top of that, sodium levels can drop faster and further. NSAIDs like naproxen can also contribute, as they affect how the kidneys handle water and sodium. If you’re on a combination of these medications, your risk is notably higher than someone on an SSRI alone.
Symptoms by Severity
Mild hyponatremia (sodium between 130 and 135 mmol/L) often produces no obvious symptoms. You might feel slightly off, a bit foggy, or mildly nauseated, but many people don’t notice anything at all. This level is frequently caught only on routine blood work.
Moderate hyponatremia (125 to 129 mmol/L) starts to cause clearer symptoms: headache, confusion, fatigue, muscle cramps, and unsteadiness. In older adults, this can look like a sudden cognitive decline or increased fall risk, which sometimes gets misattributed to aging or the depression itself rather than to the medication.
Severe hyponatremia (below 125 mmol/L) is a medical emergency. Symptoms can include seizures, respiratory failure, loss of consciousness, and in rare cases, death. The brain is particularly vulnerable because as sodium drops, water shifts into brain cells, causing them to swell inside the rigid skull.
What Happens When It’s Caught
The first step is usually identifying and addressing the SSRI as the likely cause. What happens next depends on severity.
In mild, asymptomatic cases (sodium at or above 130 mmol/L), the dose is typically reduced or gradually tapered rather than stopped abruptly. This avoids triggering withdrawal symptoms or a psychiatric relapse while giving sodium levels a chance to recover. Restricting fluid intake to roughly 500 to 1,000 mL per day is the standard approach to help sodium levels climb back up.
In moderate to severe cases, or when symptoms are present, the SSRI is usually stopped immediately. Sodium levels generally return to normal between 2 and 28 days after discontinuation. During that window, fluid restriction remains important. For severe cases requiring hospitalization, concentrated salt solutions can be administered intravenously, but sodium correction has to be carefully controlled. Raising sodium too quickly carries its own serious risk: a condition called osmotic demyelination that can damage the brain’s nerve fibers.
For people whose depression is well controlled only on an SSRI, stopping the medication isn’t a simple decision. Clinicians weigh the severity of the sodium drop against the risk of psychiatric deterioration, withdrawal, or rebound symptoms. In some cases, the SSRI is switched to a different antidepressant class that’s less likely to trigger SIADH, while monitoring sodium closely during the transition.
Monitoring During Treatment
Because the risk window peaks in the first two weeks, checking sodium levels before starting an SSRI and again within the first one to two weeks provides the best chance of catching a drop early. This is especially important for adults over 65, people already on diuretics, and anyone with a history of low sodium. If your sodium is stable after a few weeks, the ongoing risk decreases, though it doesn’t disappear entirely, as cases have been reported even after months of stable use.